LEADING-EDGE TECHNOLOGIES

In the viral vector space ELEVECTA® is the technology of choice for AAV manufacturing. For RCA-free Adenoviral vectors, Lentiviral vectors, viral vaccines, Oncolytic viruses, and Exosomes the CAP® Technology is the perfect fit. CAP®Go is the solution to enable the production of complex and highly glycosylated recombinant proteins.

STABLE AAV PRODUCER CELL LINES

With the ELEVECTA® Technology CEVEC has developed the only genuine AAV Producer Cell Line. All components necessary for AAV production are stably integrated into the producer cell.

VIRAL VECTORS, VACCINES AND EXOSOMES

CEVEC’s CAP® Technology based on human suspension cells is the ideal production platform for RCA-free Adenoviral vectors. As CAP® is based on one of the best documented and most thoroughly tested cell lines available, it is as well the platform of choice for viral vaccines, Lentiviral vectors, Oncolytic viruses, and Exosomes.

GLYCO-OPTIMIZED PROTEINS

With CAP®Go CEVEC provides a solution to enable recombinant production of complex and highly glycosylated proteins, including Laminins, Blood Coagulation Factors and other Plasma Proteins. A wide range of specifically engineered cell lines is available.

© CEVEC Pharmaceuticals GmbH 2020